Меню
Идёт набор NCT07263074

Considering alloHCT: Opportunities for Patient Reflection During Decision-Making Via Digital Stories

Без фазы С лечением Myeloid Malignancy

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: CHORDS.
Кому может быть актуально
Состояния в реестре: Myeloid Malignancy. Базовые параметры: от 21 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
США
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Feasibility and Preliminary Efficacy of a Digital Story Intervention to Facilitate Decision-Making in Patients With Myeloid Cancers Considering Allogeneic Hematopoietic Cell Transplantation

Обзор

This is a two-arm pilot randomized trial that assesses the feasibility and preliminary efficacy of a digital story and values clarification intervention (Considering alloHCT: Opportunities for Patient Reflection During Decision-Making via Digital Stories \[CHORDS\]) compared to usual care among patients with myeloid cancers considering allogeneic hematopoietic cell transplantation (alloHCT).

Подробное описание

Our proposed intervention is Considering alloHCT: Opportunities for Patient Reflection During Decision-Making via Digital Stories (CHORDS), which includes: 1) real-life digital stories of individuals with similar experiences who previously underwent consultation for allogeneic hematopoietic cell transplantation and their caregivers and 2) explicit values clarification exercises designed to help patients reflect on their emotions and clarify what matters to them, including a) an interactive workbook, and b) best-worst scaling. Together, they help patients reflect on their values and prioritize their own needs and goals, enhance emotional awareness, and gain experiential knowledge from peers to better understand the real-life implications of treatment risks and benefits.

Вмешательства

  • Другое CHORDS
    The CHORDS intervention consists of 1) digital stories created by individuals who previously underwent consultation for alloHCT and 2) explicit values clarification exercises designed to help patients reflect on their emotions and clarify what matters to them, including a) an interactive workbook, and b) best-worst scaling (BWS).

Первичные конечные точки

  • Percentage of Participants Retained (Feasibility - Retention Rate) [Срок оценки: From enrollment (Day -30 to Day 0) to 2 weeks post-alloHCT office visit (Day 9-19)]
Вторичные конечные точки (3)
  • Mean Change in Decisional Engagement Scale Score [Срок оценки: Baseline (Day -30 to Day 0) to 2 weeks post-alloHCT office visit (Day 9-19)]
  • Mean Change in Decisional Conflict Scale Score [Срок оценки: Baseline (Day -30 to Day 0) to 2 weeks post-alloHCT office visit (Day 9-19)]
  • Mean Change in Distress Thermometer Score [Срок оценки: Baseline (Day -30 to Day 0) to 2 weeks post-alloHCT office visit (Day 9-19)]

Критерии участия

Patients

Критерии включения

  • Age >21 years old
  • Diagnosis of myeloid cancer (e.g. AML, MDS, myelofibrosis, CML, or MDS/MPN)
  • Being considered for alloHCT
  • Able to provide informed consent
  • Able to speak English. The reason for this is because the digital stories have been created in the English language and their multimedia form cannot easily be translated.

Exclusion criteria 1) Patients with psychiatric or cognitive conditions which the hematologist believes prohibits informed consent or compliance with study procedures

Caregivers

Критерии включения

  • Age >18 years old
  • Selected by the patient when asked if there is a "family member, partner, friend or caregiver with whom you discuss or who can be helpful in health-related matters."
  • Caregiver may be paid/professional or informal caregiver
  • Able to provide informed consent
  • Able to speak English

Критерии исключения

1\) None

Hematologists

Критерии включения

1\) Hematologists of the patients who agree to enroll on the study who are part of WCI.

Критерии исключения

1\) None

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение
Рандомизированное
Модель
Параллельные группы
Маскирование
Открытое
Основная цель
Поддерживающая терапия

Центры проведения

США · 1 центр
  • University of Rochester — Rochester

Идентификаторы

NCT: NCT07263074 · UOCPC25049

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗